+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


2020 Influenza Vaccine Production and Distribution Market Report

  • ID: 5221337
  • Report
  • December 2020
  • Region: Global
  • 20 Pages
  • Health Industry Distributors Association (HIDA)

The 2020-2021 flu season will be the first full influenza season coinciding with the COVID-19 pandemic, creating concerns of potential coinfections and overwhelmed hospitals. The 2020 HIDA Influenza Vaccine Production & Distribution Market Report provides insights into the upcoming flu season including the impact of COVID-19, vaccine makeup, vaccine effectiveness, and reimbursement. Insights include:

  • COVID-19 spurs production of approximately 15% more flu vaccine doses
  • Flu vaccination prevented 105,000 hospitalizations and 6,300 deaths in 2019-2020
  • 52% of Americans received a vaccine last season; experts this year target a 70% vaccination rate
Note: Product cover images may vary from those shown
  • Executive Summary
  • First Full Season Of Influenza With COVID-19 Creates Uncertainty
  • Early Reports From Southern Hemisphere May Indicate Weakened Flu Season
  • Manufacturers Producing 194–198 Million Vaccine Doses For 2020–2021
  • 2020–2021 Flu Season New/Updated Vaccines
  • U.S. Influenza Vaccines 2020–21 Season
  • Flu Vaccine Locations Expected To Shift Under COVID-19
  • Influenza Vaccine For Children Hit 10-Year High in 2018–2019
  • ED Visits And Mortality Among Influenza And COVID-19 Like Illnesses
  • Children Account For Highest Percentage Of Outpatient Visits
  • Vaccine Effectiveness In 2019–2020 Was 39%
  • U.S. Government Contracts With Industry To Produce Vaccine Supplies
  • Reimbursement Rates For Influenza Vaccine
  • Testing Methods For Influenza
  • Distributors Play Large Role In Vaccine Delivery
  • Flu Vaccines Prevent Hospitalizations And Death
Note: Product cover images may vary from those shown